chartexchange

INM
InMed Pharmaceuticals Inc. Common Shares
stockNASDAQ

At CloseOct 2, 2026
1.33USD-1.481%(-0.02)28,338
Pre-marketOct 1, 2026 8:04:30 AM EDT
1.30USD-3.704%(-0.05)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Vancouver, BC, Canada
Previous Close
$1.35
Beta
0.41
52-Week High
$2.50 2025-10-08
52-Week Low
$0.58 2026-03-31
SMA 50
$1.42
SMA 200
$1.18
Avg. Vol 10D
61,910
Avg. Vol 30D
71,065
Avg. Vol 90D
675,379
Relative Vol
0.40
4.08M
145.7800%
1,418
Nov 5, 2026 (31d)
Nov 14, 2024 · 1-for-20 (reverse)
INM Profile

inmed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. inmed's proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.

INM Performance
PeriodPriceDateChangeBeta
1W1.362026-09-28-2.21%-1.563
1M1.382026-09-04-3.62%1.701
3M1.612026-07-06-17.39%-0.215
6M0.692026-04-06+91.45%-1.536
1Y2.292025-10-03-41.92%0.415
2Y4.042024-10-04-67.11%—
5Y835.002021-10-04-99.84%1.103
INM Stock Summary

InMed Pharmaceuticals Inc. Common Shares (NASDAQ:INM) stock price today is $1.33, and today's volume is 28,338. INM is down 1.481% today. The 30 day average volume is 71,065. INM market cap is $7.31M with 5.49M shares outstanding.